Dimensional Printing Industrial rapid prototyping techniques are invaluable in accelerating the transformation process from design to finished product. Three Dimensional Printing (3DP) is an Solid Freedom Fabrication (SSF) technology which are developed by MIT researchers in 1990. 3DP follows a slicing algorithm from a CAD file, and manufactures three dimensional objects by """"""""'printing"""""""" droplets of binder onto a stack of two-dimensional powder layers. Depending on the purpose of the final part, the appropriate liquid binder is selectively sprayed (i.e. printed) sequentially onto each layer of powder in a raster-scan fashion, precise patterns can be produced in two dimensions. This process is repeated in a layer-by-layer fashion until the entire three dimensional object is completed. After the unbound powder is separated from the printed part, the appropriate processing procedures, if any, are performed depending on the materials used, and the ultimate purpose of the printed part. The flexibility and adaptability of 3DP, plus its ability to control microstructure and composition, sets 3DP apart from all other rapid prototyping techniques. Prior to this project, only ceramic and metal powders have been studied in 3DP. Our research term a MIT is attempting to merge two developing technologies (3DP and biomaterials processing). Degradable polymeric materials of interest include poly-caprolactone, polyglycolic acid, polylactic acid, and their copolymers. Poly--caprolactone (PCL) is a semicrystalline polymer with high solubility, low melting point, and exceptional ability to blend with other polymers. PCL is the principal matrix material in Capronor, a one year implantable contraceptive device. Polyglycolic acid (PGA) is the simplest linear, aliphatic polyester with high crystallinity and melting point. It degrades rapidly and is used clinically as a resorbable suture, Dexon. An additional methyl group makes polylactic acid more hydrophobic than PGA. This reduced water uptake decreases the rate of PLA backbone hydrolysis, as compared to PGA. PLA-PGA coplymers are less crystalline than either pure PLA or pure PGA. This decreased crystallinity is associated with increased rate of hydrolysis. These copolymers degrade more rapidly, and their clinical application can be found in sutures (Vicryl). One of our goals is to define the limits and explore the possibilities of using these types of polymers in 3DP. Experiments are performed to study the fundamental processes in powder processing, classification, spreading, solvent solubility, jet stability, powder-solvent binding and printing behavior. Feature size, dimensional accuracy, and processing distortion are studied with various materials and printing parameters. A range of build strategies using different polymeric and inorganic powders with a number of binders are investigated to establish a fundamental understanding of the specific relationship between material properties and processing parameters. Once the basic science is quantified, our team began preliminary investigations on a revolutionary concept of exploiting 3DP's ability to produce polymeric medical devices with anisotropic microstructures and heterogeneous compositions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
3K16DE000275-05S1
Application #
3732448
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
McDermott, Nancy E; Chuang, Sung-Kiang; Woo, Valerie V et al. (2006) Maxillary sinus augmentation as a risk factor for implant failure. Int J Oral Maxillofac Implants 21:366-74
Chuang, S K; Cai, T; Douglass, C W et al. (2005) Frailty approach for the analysis of clustered failure time observations in dental research. J Dent Res 84:54-8
Chuang, S-K; Hatch, J P; Rugh, J et al. (2005) Multi-center randomized clinical trials in oral and maxillofacial surgery: modeling of fixed and random effects. Int J Oral Maxillofac Surg 34:341-4
Treister, Nathaniel S; Woo, Sook-Bin; O'Holleran, Eileen W et al. (2005) Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 11:721-31
Woo, Valerie V; Chuang, Sung-Kiang; Daher, Shadi et al. (2004) Dentoalveolar reconstructive procedures as a risk factor for implant failure. J Oral Maxillofac Surg 62:773-80
Halpern, Leslie R; Carter, Jeffrey B; Chuang, Sung-Kiang et al. (2003) A comparison of 2 consultation and treatment strategies to manage impacted third molars. J Oral Maxillofac Surg 61:779-84
Basile, John R; Eichten, Alexandra; Zacny, Valerie et al. (2003) NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res 1:262-70
McDermott, Nancy E; Chuang, Sung-Kiang; Woo, Valerie V et al. (2003) Complications of dental implants: identification, frequency, and associated risk factors. Int J Oral Maxillofac Implants 18:848-55
Chuang, S K; Tian, L; Wei, L J et al. (2002) Predicting dental implant survival by use of the marginal approach of the semi-parametric survival methods for clustered observations. J Dent Res 81:851-5
Chuang, S K; Wei, L J; Douglass, C W et al. (2002) Risk factors for dental implant failure: a strategy for the analysis of clustered failure-time observations. J Dent Res 81:572-7

Showing the most recent 10 out of 32 publications